Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The capsular polysaccharide (CPS) of *Streptococcus pneumoniae* is a high-molecular-weight, surface-exposed carbohydrate polymer that forms the outermost layer of the bacterium. It is a critical virulence factor, protecting the organism from host immune mechanisms. There are 98 recognized serotypes, each with unique chemical structures and immunological properties. The CPS is the primary target for current pneumococcal vaccines, and widespread vaccine use has altered disease epidemiology through serotype replacement.
Antibodies generated against CPS promote opsonization and phagocytosis of Streptococcus pneumoniae.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Streptococcus pneumoniae Capsular Polysaccharide (Multiple Serotypes) (CPS).